|
KIF21A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.993700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.469600E-01 |
| Normal-vs-Stage2 |
3.934400E-01 |
| Normal-vs-Stage3 |
1.12059999946013E-07 |
| Normal-vs-Stage4 |
4.556300E-04 |
| Stage1-vs-Stage2 |
2.757200E-01 |
| Stage1-vs-Stage3 |
4.822700E-04 |
| Stage1-vs-Stage4 |
1.696240E-02 |
| Stage2-vs-Stage3 |
2.122000E-02 |
| Stage2-vs-Stage4 |
4.339700E-02 |
| Stage3-vs-Stage4 |
4.425800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.698300E-02 |
| Normal-vs-AfricanAmerican |
9.178400E-02 |
| Normal-vs-Asian |
9.065000E-01 |
| Caucasian-vs-AfricanAmerican |
5.785400E-01 |
| Caucasian-vs-Asian |
3.427200E-01 |
| AfricanAmerican-vs-Asian |
2.379200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.028100E-02 |
| Normal-vs-Female |
2.305600E-01 |
| Male-vs-Female |
4.462200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.219720E-02 |
| Normal-vs-Age(41-60Yrs) |
4.809200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.381500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.079200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.215800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.170200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.211400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.123000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.755400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.702500E-02 |
| Normal-vs-Grade 2 |
1.206180E-01 |
| Normal-vs-Grade 3 |
9.730100E-02 |
| Normal-vs-Grade 4 |
1.5912999999923E-06 |
| Grade 1-vs-Grade 2 |
3.935800E-01 |
| Grade 1-vs-Grade 3 |
4.739200E-01 |
| Grade 1-vs-Grade 4 |
3.472200E-01 |
| Grade 2-vs-Grade 3 |
8.522400E-01 |
| Grade 2-vs-Grade 4 |
3.022800E-03 |
| Grade 3-vs-Grade 4 |
7.860900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.499980E-01 |
| Normal-vs-ccB subtype |
8.149800E-01 |
| ccA subtype-vs-ccB subtype |
6.420600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.391000E-01 |
| Normal-vs-N1 |
1.380400E-04 |
| N0-vs-N1 |
5.406500E-04 |
|
|
